{"id":1672,"date":"2020-01-27T08:45:53","date_gmt":"2020-01-27T08:45:53","guid":{"rendered":"https:\/\/www.aisperu.org.pe\/paginaNueva\/?p=1672"},"modified":"2025-04-14T17:31:11","modified_gmt":"2025-04-14T17:31:11","slug":"agilizar-ingreso-de-biosimilares","status":"publish","type":"post","link":"https:\/\/aisperu.org.pe\/cms\/agilizar-ingreso-de-biosimilares\/","title":{"rendered":"Agilizar ingreso de biosimilares"},"content":{"rendered":"\n<p class=\"wp-block-paragraph\">El ingreso de medicamentos biosimilares al mercado es una estrategia efectiva para facilitar el acceso a tratamientos. Para los sistemas de salud los hace menos pesados financieramente. La Agencia Europea de Medicamentos (EMA) ha autorizado desde el 2006 a la fecha (03\/01\/2020) 69 biosimilares.<br>En el Per\u00fa, luego de la reglamentaci\u00f3n del registro de los productos biosimilares en el 2016 , se ha aprobado 05 de estos productos que han sido adquiridos por diferentes instituciones p\u00fablicas, reduciendo el precio en algunos casos en m\u00e1s del 60%.<\/p>\n\n\n\n<div class=\"wp-block-buttons is-content-justification-center is-layout-flex wp-block-buttons-is-layout-flex\">\n<div class=\"wp-block-button\"><a class=\"wp-block-button__link\" href=\"https:\/\/aisperu.org.pe\/cms\/wp-content\/uploads\/2021\/06\/Nota_informativa_BIO.pdf\" target=\"_blank\" rel=\"noreferrer noopener\">Descargar<\/a><\/div>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>El ingreso de medicamentos biosimilares al mercado es una estrategia efectiva para facilitar el acceso a tratamientos. Para los sistemas de salud los hace menos pesados financieramente. La Agencia Europea de Medicamentos (EMA) ha autorizado desde el 2006 a la fecha (03\/01\/2020) 69 biosimilares.En el Per\u00fa, luego de la reglamentaci\u00f3n del registro de los productos [&hellip;]<\/p>\n","protected":false},"author":1,"featured_media":1865,"comment_status":"closed","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_coblocks_attr":"","_coblocks_dimensions":"","_coblocks_responsive_height":"","_coblocks_accordion_ie_support":"","_eb_attr":"","hide_page_title":"","footnotes":""},"categories":[11],"tags":[],"class_list":["post-1672","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-publicaciones"],"_links":{"self":[{"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/posts\/1672","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/users\/1"}],"replies":[{"embeddable":true,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/comments?post=1672"}],"version-history":[{"count":1,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/posts\/1672\/revisions"}],"predecessor-version":[{"id":5938,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/posts\/1672\/revisions\/5938"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/media\/1865"}],"wp:attachment":[{"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/media?parent=1672"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/categories?post=1672"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/aisperu.org.pe\/cms\/wp-json\/wp\/v2\/tags?post=1672"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}